Arbutus Biopharma Corp at UBS Global Healthcare Conference (Virtual) Transcript
Good morning. And thank you for attending the 2020 Virtual UBS Global Healthcare Conference. My name is Pehlaaj Bajwa, and I'll be your host for this session. (Operator Instructions) I'm pleased to introduce our presenter, Bill Collier, President and Chief Executive Officer from Arbutus Biopharma. Bill, please go ahead.
Thank you very much, Pehlaaj. And good morning, everybody. Thank you so much for your interest in Arbutus. And I'm very pleased to summarize for you all today our company mission and our achievements. As you know, we're a biopharma company, dedicated to discovering, developing and commercializing a cure for people living with chronic hepatitis B infection. And we're advancing multiple drug candidates that could be combined into a potentially curative regimen for chronic hepatitis B infection.
I'm told I need to alert you when I'm moving on. So I'm now moving on to Slide 2, which contains our forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |